Literature DB >> 31301452

Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment.

Catherine Le Berre1, Ashwin N Ananthakrishnan2, Silvio Danese3, Siddharth Singh4, Laurent Peyrin-Biroulet5.   

Abstract

It is unclear whether ulcerative colitis (UC) is a progressive disease similar to Crohn's disease (CD). Patients with UC often are undertreated because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD. We discuss findings from studies that aimed to determine whether UC and CD have the same disease burden and should be treated in the same intensive way. We discuss the similarities between CD and UC, including effects on quality of life, long-term complications, strictures, increased risk of cancer, pseudopolyps, functional abnormalities, and anorectal dysfunction. Contrary to the generally accepted idea, surgery cannot cure UC. Postoperative complications, especially pouchitis and fecal incontinence, affect more than one third of patients. CD and UC each pose substantial economic burdens. Monitoring, treatments, and goals of therapy are similar for all inflammatory bowel diseases. Earlier initiation of disease-modifying drugs might reduce the progression of UC and reduce its burden after surgery, although UC might not cause the irreversible damage observed in patients with CD.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disability; IBD; Severity; Treat to Target

Mesh:

Year:  2019        PMID: 31301452     DOI: 10.1016/j.cgh.2019.07.005

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

1.  Transmural Inflammation, Ileitis, and Granulomas at the Time of Proctocolectomy in Patients with Ulcerative Colitis Do Not Predict Future Development of Pouchitis.

Authors:  Edward L Barnes; Joshua Hudson; Scott Esckilsen; Bharati Kochar; Michael D Kappelman; Millie D Long; Mark Koruda; Robert S Sandler; Hans H Herfarth
Journal:  Inflamm Intest Dis       Date:  2021-10-07

Review 2.  Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.

Authors:  Anitha Sriram; Suma Tangirala; Srividya Atmakuri; Sajid Hoque; Sheela Modani; Saurabh Srivastava; Srushti Mahajan; Indrani Maji; Rahul Kumar; Dharmendra Khatri; Jitender Madan; Pankaj Kumar Singh
Journal:  AAPS PharmSciTech       Date:  2021-11-03       Impact factor: 3.246

3.  Plant green pigment of chlorophyllin attenuates inflammatory bowel diseases by suppressing autophagy activation in mice.

Authors:  Tianci Zhang; Ruofei Zhang; Guangfu Zhao; Wei Liu; Liwei Pan; Ying Tong; Mingshan Jiang; Hu Zhang; Zhixiong Xiao; Stephen J Pandol; Xiansheng Fu; Yuan-Ping Han; Xiaofeng Zheng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-05-31       Impact factor: 4.871

4.  Ursolic Acid Regulates Intestinal Microbiota and Inflammatory Cell Infiltration to Prevent Ulcerative Colitis.

Authors:  Qinsong Sheng; Fei Li; Guanping Chen; Jiacheng Li; Jing Li; YiFan Wang; Yingyan Lu; Qun Li; Mingqian Li; Kequn Chai
Journal:  J Immunol Res       Date:  2021-04-30       Impact factor: 4.818

Review 5.  Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough.

Authors:  Aderson Omar Mourão Cintra Damião; Natália Sousa Freitas Queiroz
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

Review 6.  Changes in the anterior cingulate cortex in Crohn's disease: A neuroimaging perspective.

Authors:  Ning Kong; Chen Gao; Maosheng Xu; Xuning Gao
Journal:  Brain Behav       Date:  2020-12-12       Impact factor: 2.708

7.  Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.

Authors:  Ewa Żyła; Katarzyna Dziendzikowska; Dariusz Kamola; Jacek Wilczak; Rafał Sapierzyński; Joanna Harasym; Joanna Gromadzka-Ostrowska
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

8.  Colon Expression of Chemokines and Their Receptors Depending on the Stage of Colitis and Oat Beta-Glucan Dietary Intervention-Crohn's Disease Model Study.

Authors:  Łukasz Kopiasz; Katarzyna Dziendzikowska; Joanna Gromadzka-Ostrowska
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

9.  Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.

Authors:  Sofia Nene; Lorant Gonczi; Zsuzsanna Kurti; Isabelle Morin; Kelly Chavez; Christine Verdon; Jason Reinglas; Rita Kohen; Talat Bessissow; Waqqas Afif; Gary Wild; Ernest Seidman; Alain Bitton; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2020-02-21       Impact factor: 5.742

10.  The Periodontopathic Pathogen, Porphyromonas gingivalis, Involves a Gut Inflammatory Response and Exacerbates Inflammatory Bowel Disease.

Authors:  Yu-Chen Lee; Chih-Yi Liu; Chia-Long Lee; Ruo-Han Zhang; Chi-Jung Huang; Ting-Lin Yen
Journal:  Pathogens       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.